Published • loading... • Updated
Pfizer Inc. (NYSE:PFE) Given Average Recommendation of "Hold" by Analysts
Summary by marketbeat.com
2 Articles
2 Articles
Pfizer Inc. (NYSE:PFE) Given Average Recommendation of "Hold" by Analysts
Shares of Pfizer Inc. (NYSE:PFE - Get Free Report) have received an average recommendation of "Hold" from the twenty-three research firms that are currently covering the company, MarketBeat.com reports. Three research analysts have rated the stock with a sell recommendation, fourteen have issued a
Pfizer (NYSE:PFE) Raised to “Buy” at Argus
Pfizer (NYSE:PFE – Get Free Report) was upgraded by Argus from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday, Marketbeat reports. The firm presently has a $35.00 price objective on the biopharmaceutical company’s stock. Argus’ price objective would indicate a potential upside of 31.58% from […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
